Med Life (LTS:0RO5) Other Financing: lei-7 Mil (TTM As of Mar. 2026)


LTS:0RO5 Med Life SA LTS:0RO5
75 GF Score
Price lei11.38
GF Value lei1.39
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Med Life Other Financing?

Med Life LTS:0RO5 75 Other Financing is lei-7 Mil as of Mar. 2026. GuruFocus rates LTS:0RO5 with a GF Score™ of 75/100 and a GF Value™ of lei1.39 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Med Life's Other Financing for the three months ended in Mar. 2026 was lei-2 Mil.

Med Life's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was lei-7 Mil.

Med Life Other Financing Historical Data

* Premium members only.

The historical data trend for Med Life's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Med Life Other Financing Chart

Med Life Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.70 1.94 -6.66 -8.38 -0.79

Med Life Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -2.42 -3.73 -0.90 -2.06
LTS:0RO5
75GF Score
Med Life SA LTS:0RO5
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Med Life Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was lei-7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of lei-7 Mil mean?
Med Life (LTS:0RO5) has a Other Financing of lei-7 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Med Life and its competitors.
Is Med Life's Other Financing too high?
Med Life's current Other Financing is lei-7 Mil. Overall, Med Life has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Med Life's Other Financing compare to HCA and THC?
Med Life's Other Financing of lei-7 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Med Life and its competitors. Med Life's current Other Financing is lei-7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med Life stock overvalued right now?
Based on GuruFocus' analysis, Med Life (LTS:0RO5) is currently considered Significantly Overvalued. The stock's GF Value™ is lei1.39, compared to a current price of lei11.38 — trading 718.4% above its estimated fair value. The current Other Financing is lei-7 Mil. Med Life's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Med Life (LTS:0RO5), the current Other Financing is lei-7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Med Life (LTS:0RO5) Overvalued in 2026?

Based on GuruFocus' analysis, Med Life stock appears to be overvalued. The current stock price of lei11.38 is trading 718.4% above its estimated GF Value™ of lei1.39. GuruFocus considers Med Life to be Significantly Overvalued.

Key valuation signals for LTS:0RO5:

  • Other Financing: lei-7 Mil
  • GF Value™: lei1.39 vs. price of lei11.38 (718.4% above fair value)
  • GF Score™: 75/100 with 4 warning signs

No single metric tells the full story. See the LTS:0RO5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Med Life Business Description

Other Exchanges M:RomaniaO0C:Germany
Address Calea Grivitei, No. 365, District 1, Bucharest, ROU
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
75GF Score

Get the complete analysis for LTS:0RO5

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei11.38
Price
lei1.39
GF Value